Celera Signs First Taiwanese Subscriber to CDS | GenomeWeb

NEW YORK, March 19 – Celera Genomics said Monday it signed its first Taiwanese customer for the Celera Discovery System.

Vita Genomics, a start-up focused on studying diseases prevalent in Asian populations, said it would use the information and tools contained in the database to better understand diseases as well as to create diagnostics and therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.